In a recent press release, the Internal Revenue Service advised that cannabis companies refrain from taking federal tax deductions for business expenses. While these deductions are provided for other businesses under section 280E, cannabis businesses aren’t allowed to mainly because the drug is still a controlled substance.
Section 280E doesn’t allow credits or deductions for any amount incurred or paid in conducting any business or trade that includes trafficking a Schedule 1 or 2 substance. This applies to businesses that sell cannabis, even if they operate in legal states. Currently, cannabis is classified as a Schedule 1 substance under the Controlled Substances Act. However, the drug may soon be moved to Schedule III once the Department of Justice completes its review.
In its press release, the IRS explained that cannabis was subject to the limitations of the Internal Revenue Code and any taxpayer who sought a refund of taxes paid related to the aforementioned statute by filing amended returns wasn’t entitled to a payment or refund.
This statement comes at a time when some multistate cannabis operators have begun seeking refunds for the “excess” taxes they paid in the previous years because of Section 280E. For instance, Trulieve recently revealed that it applied for and received $113 million in refunds. The company is the primary backer of a legalization campaign in Florida.
Ascend Wellness and TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) have also disclosed that they are expecting refunds. However, this doesn’t align with the IRS’ statement, with the body noting that while the grounds for these claims often varied, they were working on addressing claims filed.
The IRS explained that the Department of Justice hadn’t finalized its recommendation to reclassify cannabis, adding that there was an open public-comment period ongoing. In addition, the agency noted that it was possible the proposed change in policy would be subjected to an administrative hearing review.
It should be noted that the IRS 280E statute doesn’t forbid an individual in the industry from reducing gross receipts by calculating the cost of goods sold to determine gross income.
Meanwhile, some states have taken steps to offer tax relief to cannabis businesses subject to section 280E despite the federal rule not having changed. In April 2023, Representative Earl Blumenauer reintroduced a resolution that would alter the IRS code to permit state-legal cannabis businesses to take federal tax deductions afforded to companies in other industries. This comes after the Congressional Research Service noted that the IRS had provided little guidance on how Section 280E would be applied.
About CannabisNewsWire
CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN